According to Palatin Technologies's latest financial reports the company's current EPS (TTM) is A-$1.87. In 2022 the company made an earnings per share (EPS) of A-$4.22 an increase over its 2021 EPS that were of A-$5.62.
Year | EPS | Change |
---|---|---|
2025 (TTM) | A-$1.86 | |
2022 | A-$4.22 | -24.86% |
2021 | A-$5.62 | 33.09% |
2020 | A-$4.22 | |
2014 | A-$0.38 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() MediciNova MNOV | A-$0.35 | -81.15% | ๐บ๐ธ USA |
![]() GlycoMimetics
GLYC | A-$0.80 | -57.38% | ๐บ๐ธ USA |
![]() Neurocrine Biosciences
NBIX | A$4.65 | -348.36% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | A-$1.93 | 3.28% | ๐บ๐ธ USA |
![]() Ligand Pharmaceuticals LGND | A-$10.93 | 483.61% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | A$13.92 | -843.25% | ๐บ๐ธ USA |
![]() Ardelyx ARDX | A-$0.25 | -86.60% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | A$3.84 | -305.33% | ๐ฌ๐ง UK |